These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2596504)

  • 1. Nocturnal rhythm of growth hormone in Duchenne patients: effect of different doses of mazindol and/or cyproheptadine.
    Zatz M; Rapaport D; Pavanello RC; Rocha JM; Vainzof M; Nicolau W
    Am J Med Genet; 1989 Aug; 33(4):457-67. PubMed ID: 2596504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mazindol on growth hormone levels in patients with Duchenne muscular dystrophy.
    Zatz M; Rapaport D; Vainzof M; Pavanello Rde C; Rocha JM; Betti RT; Otto PA
    Am J Med Genet; 1988 Dec; 31(4):821-33. PubMed ID: 3239574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.
    Zatz M; Betti RT; Frota-Pessoa O
    Am J Med Genet; 1986 Jul; 24(3):549-66. PubMed ID: 3524231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of mazindol on growth hormone secretion in boys with Duchenne muscular dystrophy.
    Coakley JH; Moorcraft J; Hipkin LJ; Smith CS; Griffiths RD; Edwards RH
    J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1551-7. PubMed ID: 3221222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind trial of mazindol in Duchenne dystrophy.
    Griggs RC; Moxley RT; Mendell JR; Fenichel GM; Brooke MH; Miller PJ; Mandel S; Florence J; Schierbecker J; Kaiser KK
    Muscle Nerve; 1990 Dec; 13(12):1169-73. PubMed ID: 2266990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mazindol and growth hormone inhibition in Duchenne muscular dystrophy.
    Zatz M; Vainzof M; Rapaport D; da Rocha JM; Pavanello Rde C; Betti RT
    Am J Med Genet; 1987 Aug; 27(4):993-5. PubMed ID: 3321999
    [No Abstract]   [Full Text] [Related]  

  • 7. Physiological assessment of growth hormone secretion in the diagnosis of children with short stature.
    Saggese G; Meossi C; Cesaretti G; Bottone E
    Pediatrician; 1987; 14(3):121-37. PubMed ID: 2899313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone inhibition causes increased selenium levels in Duchenne muscular dystrophy: a possible new approach to therapy.
    Collipp PJ; Kelemen J; Chen SY; Castro-Magana M; Angulo M; Derenoncourt A
    J Med Genet; 1984 Aug; 21(4):254-6. PubMed ID: 6492089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A therapeutic trial of mazindol versus placebo in Duchenne muscular dystrophy. A one-year follow-up study of 14 children].
    Desnuelle C; Serratrice G; N'guyen VK; Richelme C; Pinsard N
    Arch Fr Pediatr; 1989 Dec; 46(10):759-65. PubMed ID: 2697199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyproheptadine on the spontaneous diurnal variations of plasma ACTH-cortisol and ACTH-GH secretion induced by l-dopa.
    Delitala G; Masala A; Alagna S; Devilla L
    Biomedicine; 1975 Dec; 23(10):406-9. PubMed ID: 177112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal polyamine metabolism in hereditary muscular dystrophies: effect of human growth hormone.
    Rudman D; Kutner MH; Chawla RK; Goldsmith MA
    J Clin Invest; 1980 Jan; 65(1):95-102. PubMed ID: 7350201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mazindol in Duchenne muscular dystrophy.
    Coakley JH; Edwards RH; Moorcraft J; Hipkin LJ; Smith CS
    Lancet; 1988 Jan; 1(8578):184. PubMed ID: 2893022
    [No Abstract]   [Full Text] [Related]  

  • 14. Failure of serotonin inhibitor to effect nocturnal GH and prolactin secretion in patients with Duchenne muscular dystrophy.
    Marlarkey WB; Mendall JR
    J Clin Endocrinol Metab; 1976 Oct; 43(4):889-92. PubMed ID: 135769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone evaluation in Duchenne muscular dystrophy.
    Merlini L; Granata C; Ballestrazzi A; Cornelio F; Tassoni P; Tugnoli S; Cacciari E
    Ital J Neurol Sci; 1988 Oct; 9(5):471-5. PubMed ID: 3215748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spontaneous secretion of growth hormone in deep nocturnal sleep. II. Studies on hypophyseal dwarfism and constitutional developmental delay].
    Bierich JR; Brügmann G; Kiessling E
    Monatsschr Kinderheilkd; 1989 Feb; 137(2):80-5. PubMed ID: 2716742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of a growth hormone inhibitor on the course of Duchenne's myopathy].
    Serratrice G; Desnuelle C
    Presse Med; 1988 Nov; 17(41):2201. PubMed ID: 2974583
    [No Abstract]   [Full Text] [Related]  

  • 18. Interrelations between sleep and the somatotropic axis.
    Van Cauter E; Plat L; Copinschi G
    Sleep; 1998 Sep; 21(6):553-66. PubMed ID: 9779515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of human growth hormone secretion by melatonin and cyproheptadine.
    Smythe GA; Lazarus L
    J Clin Invest; 1974 Jul; 54(1):116-21. PubMed ID: 4600047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered nocturnal growth hormone (GH) secretion in obsessive compulsive disorder.
    Kluge M; Schüssler P; Weikel J; Dresler M; Zuber V; Querfurt F; Yassouridis A; Steiger A
    Psychoneuroendocrinology; 2006 Oct; 31(9):1098-104. PubMed ID: 16965859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.